Eli Lilly and Company (LLY) earnings: date, estimates, results and stock reactions
Next earnings: Q1 FY2027 on 2027-02-03 (expected, time not announced). EPS estimate 11.22, revenue estimate 24.58B.
Over the last 12 reports the stock moved 7.2% on average (either way), rising 9 times and falling 3. EPS beat estimates 11 of 12 times; revenue 8 of 9. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q4 FY2026 | 2026-10-29 | 7.48 | 5.71 | +31.0% | 24.40B | 22.58B | +10.0% |
| Q3 FY2026 | 2026-08-05 | 8.38 | 6.40 | +30.9% | 22.97B | 20.82B | +6.8% |
| Q2 FY2026 | 2026-04-30 | 8.55 | 6.97 | +22.7% | 19.80B | 17.82B | +13.2% |
| Q1 FY2026 | 2026-02-04 | 7.54 | 6.91 | +9.1% | 19.29B | 17.94B | +1.7% |
| Q4 FY2025 | 2025-10-30 | 7.02 | 5.69 | +23.4% | 17.60B | 16.05B | +6.1% |
| Q3 FY2025 | 2025-08-07 | 6.31 | 5.60 | +12.7% | 15.56B | 14.70B | -16.2% |
| Q2 FY2025 | 2025-05-01 | 3.34 | 3.26 | +2.5% | 12.73B | 12.67B | -8.4% |
| Q1 FY2025 | 2025-02-06 | 5.32 | 5.03 | +5.8% | 13.53B | n/a | +4.3% |